Oncology
Rising incidence across the globe
Cancer is the leading cause of death worldwide. With 11.3 million new cases of cancer in 2007, the disease remains an area of high unmet medical need. Despite advances in screening, education and early diagnosis, the global cancer burden continues to rise: New cases of cancer are estimated to jump about 37% to 15.5 million in 2030.1 This trend is set to continue due to an increasing shift towards an aging population with a high cancer risk.
Combination is key to our approach
Merck Serono Oncology is focused on developing novel cancer-specific therapies that provide beneficial therapeutic outcomes and create new options for cancer patients.
Combination is key for Merck Serono not only in developing products that target multiple aspects of the disease process and are suitable for use in combination with established standard therapies, but also for:
- Combining innovative thinking with intelligent research and technical excellence ─ Merck Serono Oncology has brought together a dedicated group of individuals who can look beyond conventional horizons to explore further possibilities. They have the experience and motivation we need to identify potential therapeutic targets and develop novel cancer treatment strategies.
- Combining insights, experience and skills ─ Merck Serono is committed to working in partnership with oncology experts, healthcare providers and patients. We strive to meet the needs of patients for better medicines, and to improve access to these medicines by collaborative teamwork and sharing of skills. Moreover, this strategy combines the efficacy of radiotherapy, surgery and medical treatments to create a multidisciplinary approach for the benefit of cancer patients everywhere.
| Disclaimer |
The information contained in these pages is intended for general reference only. It may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country. This information should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination. US Residents should consult EMD Serono, Inc. for information on products approved for sale in the United States of America. |
